SmQnrR, a DeoR-type transcriptional regulator, negatively regulates the expression of Smqnr and SmtcrA in Stenotrophomonas maltophilia.

OBJECTIVES To characterize the role of SmqnrR in the expression of Smqnr and SmtcrA, and the role of SmtcrA in drug resistance in Stenotrophomonas maltophilia. METHODS SmqnrR, a DeoR-type regulator gene, is situated between a quinolone resistance gene (Smqnr) and a putative major facilitator superfamily transmembrane transporter gene (SmtcrA). To assess the regulatory role of SmQnrR in the expression of Smqnr and SmtcrA, the transcripts of Smqnr and SmtcrA genes were determined in the wild-type KJ and the SmqnrR isogenic mutant KJΔQnrR. An SmqnrR polar mutant, KJΔQnrRΩ, was constructed to investigate the possibility that SmqnrR and SmtcrA form an operon. The contribution of Smqnr and SmtcrA genes to the intrinsic and acquired resistance of S. maltophilia was evaluated using susceptibility testing. RESULTS SmQnrR acted as a repressor for the expression of Smqnr and SmtcrA genes. SmqnrR and SmtcrA genes formed an operon, which was negatively autoregulated by SmQnrR. Smqnr and SmtcrA contributed only slightly to intrinsic resistance in S. maltophilia. Nevertheless, overexpression of Smqnr and SmtcrA by inactivating SmqnrR conferred a slight increase in quinolone MICs and a more marked increase in tetracycline MIC. CONCLUSIONS The SmQnrR protein is a transcriptional repressor for the contiguous Smqnr and SmtcrA genes, and SmQnrR is a negative regulator of SmqnrR-SmtcrA operon expression. Inactivation of SmqnrR contributes to an acquired increase in quinolone and tetracycline MICs for S. maltophilia.

[1]  N. Gordon,et al.  Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. , 2010, Journal of Antimicrobial Chemotherapy.

[2]  J. Martínez,et al.  SmQnr Contributes to Intrinsic Resistance to Quinolones in Stenotrophomonas maltophilia , 2009, Antimicrobial Agents and Chemotherapy.

[3]  楊翠青 AmpDI is involved in expression of the chromosomal L1 and L2 beta-lactamases of Stenotrophomonas maltophilia , 2009 .

[4]  P. Nordmann,et al.  Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. , 2009, Current medicinal chemistry.

[5]  J. Martínez,et al.  Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants , 2008, BMC Microbiology.

[6]  Kenichiro Shimizu,et al.  Smqnr, a New Chromosome-Carried Quinolone Resistance Gene in Stenotrophomonas maltophilia , 2008, Antimicrobial Agents and Chemotherapy.

[7]  Georgios S. Vernikos,et al.  The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants , 2008, Genome Biology.

[8]  Tsuey-Ching Yang,et al.  Induction of L1 and L2 β-Lactamases of Stenotrophomonas maltophilia , 2007, Antimicrobial Agents and Chemotherapy.

[9]  O. Lewinson,et al.  Promiscuity in multidrug recognition and transport:
 the bacterial MFS Mdr transporters , 2006, Molecular microbiology.

[10]  A. Robicsek,et al.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase , 2006, Nature Medicine.

[11]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .